SlideShare a Scribd company logo
INTERNSHIP REPORT AT
PIRAMAL PHARAMACEUTICAL LIMITED
INTERNSHIP BY
-BARATH R
(20-UCH-037)
WAREHOUSE IN PHARMAECUTICAL INDUSTRY
• To maintained Warehouse and Finished Goods area clean
and presentable for audit.To follow Good Documentation
practices and safety instructions & ensure compliance
while working in warehouse. Receiving of Raw materials
and Packing materials and Prepare Goods receipt Note
(GRN).
• Recording of Temperature, Relative Humidity and
Differential Pressure in stores and Finished Goods area.
Arrangements of Raw material and Packing material in
stores according to the status i.e Under test Approved,
Rejected and Quarantine etc. Dispensing and issue of Raw
materials and Packing materials to production and Packing
department as per respective Batch manufacturing and
Packing record.
• Handling of Damaged, Rejected and Expired materials in
warehouse. To follow online documentation in Raw material,
Packing material and Finished Goods store. Follow up with
purchase and commercial department for disposal of non
moving, obsolete and rejected raw and packing materials.
Temperature mapping in Stores and Finished Goods area.
Posting and Transaction of materials in SAP or ERP system.
Follow up with Quality control department
for timely sampling and release of
materials. Preparation of Standard
Operating Procedure related to warehouse
department. To provide SOP Training to
juniors or new joining persons. Responsible
for Handling of Change control and
Deviations. Prepare packing list and
dispatch plan for Finished Goods and
dispatch of Finished Goods. Identify the
materials which are due for Retesting on
monthly basis and inform to respective
department for sampling of the same.
PRODUCTION IN PHARMACEUTICAL INDUSTRY
• Production should be performed and supervised by competent people.All
handling of materials and products, such as receipt and quarantine,
sampling, storage, labelling, dispensing, processing, packaging and
distribution should be done in accordance with written procedures or
instructions and, where necessary, recorded.
• All incoming materials should be checked to ensure that the consignment
corresponds to the order. Containers should be cleaned where necessary
and labelled with the prescribed data.
• Damage to containers and any other problem which might adversely affect
the quality of a material should be investigated, recorded and reported to
the Quality Control Department.
• Incoming materials and finished products should be physically or
administratively quarantined immediately after receipt or processing,
until they have been released for use or distribution.
• Intermediate and bulk products purchased as such should be handled
on receipt as though they were starting materials. Checks on yields,
and reconciliation of quantities, should be carried out as necessary to
ensure that there are no discrepancies outside acceptable
limits.Operations on different products should not be carried out
simultaneously or consecutively in the same room unless there is no
risk of mix-up or crosscontamination.
• At every stage of processing, products and materials should be
protected from microbial and other contamination.
When working with dry materials and
products, special precautions should be
taken to prevent the generation and
dissemination of dust. This applies
particularly to the handling of highly active
or sensitising materials.
At all times during processing, all materials,
bulk containers, major items of equipment
and where appropriate rooms used should
be labelled or otherwise identified with an
indication of the product or material being
processed, its strength (where applicable)
and batch number. Where applicable, this
indication should also mention the stage of
production.
R&D IN PHARMA INDUSTRY
• The pharma R&D process is simply the series of activities targeted to reach
the goal of discovering and delivering new medical drugs, devices, or
therapies to market.
• Very basically, R&D in the pharma industry involves:
• Pre-clinical research and discovery of innovative drugs
• Clinical testing of prescription drugs in trials
• Preparation and submission of applications for Food and Drug
Administration or FDA approval
Designing production processes for the new
product
Clinical testing of a new drug against an existing
drug to ultimately show the new product’s
superior benefits
Additional clinical trials after a new drug reaches
the market, for safety monitoring and detection
of additional side effects that may not have been
observed in earlier trials during development
Line extensions, or innovations and
improvements for existing prescription drugs,
which include developing new dosages and
delivery systems and testing for additional
potential uses
Quality Control in the Pharmaceutical Industry
• Analyzes are performed according to what each drug requires and
depending on the phase this drug is in. In the physical-chemical laboratory,
controls of all types are carried out, from the simplest to the most
complex. We can mention as simple analyzes the product’s appearance,
hardness, density and pH. As more complex, we can mention the most
used method today in the largest pharmaceutical industries in the world,
the content of the product (dosage), carried out in a device called HPLC
(High Performance Liquid Chromatography).
• Each product goes through a production process and in a physico-chemical
laboratory it is analyzed from the raw material, passing through the initial
product, final product and stability study. Each phase requires special
attention in its tests, following the literature established by the countries of
dispatch and consumption of the drug. In Portugal, the European
Pharmacopoeia is used as the main literature.
HIGH PERFOMANCE LIQUID CHROMATOGRAPHY IN
PHARMACEUTICAL ANALYSES
• The purpose high perfomance liquid chromatography (HPLC) analysis of any drugs
is to confirm the identity of a drug and provide quantitative results and also to
monitor the progress of the therapy of a disease
• It may also be used to further our understanding of the normal and disease
process in the human body trough biomedical and therapeutically research
during investigation before of the drugs registration. The analyses of drugs and
metabolites in biological fluids, particularly plasma, serum or urine is one of the
most demanding but one of the most common uses of high performance of liquid
chromatography. Blood, plasma or serum contains numerous endogenous
compounds of ten present in concentrations much greater than those of analyte.
Analiyte concentrations are often low, and in the case of drugs, the endogenous
compounds are sometimes structurally very similar to the drug to be measured.
The binding of drugs to the plasma protein also may occur which decreases the
amount of free compound that is measured.
• Liquid chromatography is an analytical technique that is used to
separate a certain sample into its individual components.1 The
separation occurs when the sample interacts with the mobile (liquid)
and stationary phases (column). The various parts of the sample are
separated out based on their polarities; they will have varying levels
of affinity for the mobile phase, resulting in migration through the
column at different speeds.
• The mixed components are placed at the top of the column of the
stationary phase, which is generally a fine adsorbent solid such as
silica. This must be distributed evenly to minimise the presence of air
bubbles that could influence the results of the test. The exit of the
column is stoppered with glass, wool or a porous plate. When the
mobile phase passes through, the mixture separates into bands.
These can then be collected and analysed via other methods.1

More Related Content

Similar to INTERNSHIP REPORT (20).pptx

Current Good Manufacturing Practice
Current Good Manufacturing PracticeCurrent Good Manufacturing Practice
Current Good Manufacturing Practice
Chaitanya kanade
 
Warehousing & Material management
Warehousing & Material managementWarehousing & Material management
Warehousing & Material management
Teny Thomas
 
Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practices
Madhvibajaj
 
Presentation on Good Clinical Practices (GCP) By Anubhav Singh m.pharm 1st year
Presentation on Good Clinical Practices (GCP) By Anubhav Singh m.pharm 1st yearPresentation on Good Clinical Practices (GCP) By Anubhav Singh m.pharm 1st year
Presentation on Good Clinical Practices (GCP) By Anubhav Singh m.pharm 1st year
Anubhav Singh
 
Good storage practices
Good storage practicesGood storage practices
Good storage practices
Tala Khaled
 
Goodstoragepractices 190420174931
Goodstoragepractices 190420174931Goodstoragepractices 190420174931
Goodstoragepractices 190420174931
Rafhan Altaf
 
Gmp ayurveda
Gmp ayurvedaGmp ayurveda
Manufacturing operation and control
Manufacturing operation and controlManufacturing operation and control
Manufacturing operation and control
Malay Pandya
 
Quality control of drugs and pharmaceuticals
Quality control of drugs and pharmaceuticalsQuality control of drugs and pharmaceuticals
Quality control of drugs and pharmaceuticals
Revathi Gnanavelou
 
What is glp
What is glpWhat is glp
Forensic
Forensic Forensic
Forensic
urooj001
 
Good Laboratory Practices for Pharmaceutical Quality Control Laboratories
Good Laboratory Practices for Pharmaceutical Quality Control LaboratoriesGood Laboratory Practices for Pharmaceutical Quality Control Laboratories
Good Laboratory Practices for Pharmaceutical Quality Control Laboratories
Sathish Vemula
 
GOOD LABORATORY PRACTICES - A DETAILED STUDY
GOOD LABORATORY PRACTICES - A DETAILED STUDYGOOD LABORATORY PRACTICES - A DETAILED STUDY
GOOD LABORATORY PRACTICES - A DETAILED STUDY
Teny Thomas
 
Good Distribution Practices (1).pptx
Good Distribution Practices (1).pptxGood Distribution Practices (1).pptx
Good Distribution Practices (1).pptx
OwaisAhmed811958
 
Gmp & glp
Gmp & glpGmp & glp
Gmp & glp
Bidhan Mahajon
 
Good storage practices
Good storage practicesGood storage practices
Good storage practices
Bangaluru
 
warehousing[1]
 warehousing[1] warehousing[1]
warehousing[1]
Himani Chauhan
 
PROCEDURES FOR VALIDATION.docx
PROCEDURES FOR VALIDATION.docxPROCEDURES FOR VALIDATION.docx
PROCEDURES FOR VALIDATION.docx
LAURENCERAMIREZ3
 
Good manufacturing
Good manufacturingGood manufacturing
Good manufacturing
Dr. Vir Vikram
 
GOOD MANUFACTURING PRACTICES AND QUALITY ASSURANCE.pdf
GOOD MANUFACTURING PRACTICES AND QUALITY ASSURANCE.pdfGOOD MANUFACTURING PRACTICES AND QUALITY ASSURANCE.pdf
GOOD MANUFACTURING PRACTICES AND QUALITY ASSURANCE.pdf
poornima335163
 

Similar to INTERNSHIP REPORT (20).pptx (20)

Current Good Manufacturing Practice
Current Good Manufacturing PracticeCurrent Good Manufacturing Practice
Current Good Manufacturing Practice
 
Warehousing & Material management
Warehousing & Material managementWarehousing & Material management
Warehousing & Material management
 
Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practices
 
Presentation on Good Clinical Practices (GCP) By Anubhav Singh m.pharm 1st year
Presentation on Good Clinical Practices (GCP) By Anubhav Singh m.pharm 1st yearPresentation on Good Clinical Practices (GCP) By Anubhav Singh m.pharm 1st year
Presentation on Good Clinical Practices (GCP) By Anubhav Singh m.pharm 1st year
 
Good storage practices
Good storage practicesGood storage practices
Good storage practices
 
Goodstoragepractices 190420174931
Goodstoragepractices 190420174931Goodstoragepractices 190420174931
Goodstoragepractices 190420174931
 
Gmp ayurveda
Gmp ayurvedaGmp ayurveda
Gmp ayurveda
 
Manufacturing operation and control
Manufacturing operation and controlManufacturing operation and control
Manufacturing operation and control
 
Quality control of drugs and pharmaceuticals
Quality control of drugs and pharmaceuticalsQuality control of drugs and pharmaceuticals
Quality control of drugs and pharmaceuticals
 
What is glp
What is glpWhat is glp
What is glp
 
Forensic
Forensic Forensic
Forensic
 
Good Laboratory Practices for Pharmaceutical Quality Control Laboratories
Good Laboratory Practices for Pharmaceutical Quality Control LaboratoriesGood Laboratory Practices for Pharmaceutical Quality Control Laboratories
Good Laboratory Practices for Pharmaceutical Quality Control Laboratories
 
GOOD LABORATORY PRACTICES - A DETAILED STUDY
GOOD LABORATORY PRACTICES - A DETAILED STUDYGOOD LABORATORY PRACTICES - A DETAILED STUDY
GOOD LABORATORY PRACTICES - A DETAILED STUDY
 
Good Distribution Practices (1).pptx
Good Distribution Practices (1).pptxGood Distribution Practices (1).pptx
Good Distribution Practices (1).pptx
 
Gmp & glp
Gmp & glpGmp & glp
Gmp & glp
 
Good storage practices
Good storage practicesGood storage practices
Good storage practices
 
warehousing[1]
 warehousing[1] warehousing[1]
warehousing[1]
 
PROCEDURES FOR VALIDATION.docx
PROCEDURES FOR VALIDATION.docxPROCEDURES FOR VALIDATION.docx
PROCEDURES FOR VALIDATION.docx
 
Good manufacturing
Good manufacturingGood manufacturing
Good manufacturing
 
GOOD MANUFACTURING PRACTICES AND QUALITY ASSURANCE.pdf
GOOD MANUFACTURING PRACTICES AND QUALITY ASSURANCE.pdfGOOD MANUFACTURING PRACTICES AND QUALITY ASSURANCE.pdf
GOOD MANUFACTURING PRACTICES AND QUALITY ASSURANCE.pdf
 

Recently uploaded

Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit InnovationLeveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
TechSoup
 
The basics of sentences session 7pptx.pptx
The basics of sentences session 7pptx.pptxThe basics of sentences session 7pptx.pptx
The basics of sentences session 7pptx.pptx
heathfieldcps1
 
Wound healing PPT
Wound healing PPTWound healing PPT
Wound healing PPT
Jyoti Chand
 
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdfREASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
giancarloi8888
 
Skimbleshanks-The-Railway-Cat by T S Eliot
Skimbleshanks-The-Railway-Cat by T S EliotSkimbleshanks-The-Railway-Cat by T S Eliot
Skimbleshanks-The-Railway-Cat by T S Eliot
nitinpv4ai
 
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 8 - CẢ NĂM - FRIENDS PLUS - NĂM HỌC 2023-2024 (B...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 8 - CẢ NĂM - FRIENDS PLUS - NĂM HỌC 2023-2024 (B...BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 8 - CẢ NĂM - FRIENDS PLUS - NĂM HỌC 2023-2024 (B...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 8 - CẢ NĂM - FRIENDS PLUS - NĂM HỌC 2023-2024 (B...
Nguyen Thanh Tu Collection
 
How to Predict Vendor Bill Product in Odoo 17
How to Predict Vendor Bill Product in Odoo 17How to Predict Vendor Bill Product in Odoo 17
How to Predict Vendor Bill Product in Odoo 17
Celine George
 
A Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two HeartsA Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two Hearts
Steve Thomason
 
Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptxPrésentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
siemaillard
 
How to Manage Reception Report in Odoo 17
How to Manage Reception Report in Odoo 17How to Manage Reception Report in Odoo 17
How to Manage Reception Report in Odoo 17
Celine George
 
Educational Technology in the Health Sciences
Educational Technology in the Health SciencesEducational Technology in the Health Sciences
Educational Technology in the Health Sciences
Iris Thiele Isip-Tan
 
Accounting for Restricted Grants When and How To Record Properly
Accounting for Restricted Grants  When and How To Record ProperlyAccounting for Restricted Grants  When and How To Record Properly
Accounting for Restricted Grants When and How To Record Properly
TechSoup
 
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptxNEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
iammrhaywood
 
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.pptLevel 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
Henry Hollis
 
Bossa N’ Roll Records by Ismael Vazquez.
Bossa N’ Roll Records by Ismael Vazquez.Bossa N’ Roll Records by Ismael Vazquez.
Bossa N’ Roll Records by Ismael Vazquez.
IsmaelVazquez38
 
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
TechSoup
 
Bonku-Babus-Friend by Sathyajith Ray (9)
Bonku-Babus-Friend by Sathyajith Ray  (9)Bonku-Babus-Friend by Sathyajith Ray  (9)
Bonku-Babus-Friend by Sathyajith Ray (9)
nitinpv4ai
 
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdfمصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
سمير بسيوني
 
Oliver Asks for More by Charles Dickens (9)
Oliver Asks for More by Charles Dickens (9)Oliver Asks for More by Charles Dickens (9)
Oliver Asks for More by Charles Dickens (9)
nitinpv4ai
 
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
Nguyen Thanh Tu Collection
 

Recently uploaded (20)

Leveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit InnovationLeveraging Generative AI to Drive Nonprofit Innovation
Leveraging Generative AI to Drive Nonprofit Innovation
 
The basics of sentences session 7pptx.pptx
The basics of sentences session 7pptx.pptxThe basics of sentences session 7pptx.pptx
The basics of sentences session 7pptx.pptx
 
Wound healing PPT
Wound healing PPTWound healing PPT
Wound healing PPT
 
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdfREASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
REASIGNACION 2024 UGEL CHUPACA 2024 UGEL CHUPACA.pdf
 
Skimbleshanks-The-Railway-Cat by T S Eliot
Skimbleshanks-The-Railway-Cat by T S EliotSkimbleshanks-The-Railway-Cat by T S Eliot
Skimbleshanks-The-Railway-Cat by T S Eliot
 
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 8 - CẢ NĂM - FRIENDS PLUS - NĂM HỌC 2023-2024 (B...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 8 - CẢ NĂM - FRIENDS PLUS - NĂM HỌC 2023-2024 (B...BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 8 - CẢ NĂM - FRIENDS PLUS - NĂM HỌC 2023-2024 (B...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 8 - CẢ NĂM - FRIENDS PLUS - NĂM HỌC 2023-2024 (B...
 
How to Predict Vendor Bill Product in Odoo 17
How to Predict Vendor Bill Product in Odoo 17How to Predict Vendor Bill Product in Odoo 17
How to Predict Vendor Bill Product in Odoo 17
 
A Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two HeartsA Visual Guide to 1 Samuel | A Tale of Two Hearts
A Visual Guide to 1 Samuel | A Tale of Two Hearts
 
Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptxPrésentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
Présentationvvvvvvvvvvvvvvvvvvvvvvvvvvvv2.pptx
 
How to Manage Reception Report in Odoo 17
How to Manage Reception Report in Odoo 17How to Manage Reception Report in Odoo 17
How to Manage Reception Report in Odoo 17
 
Educational Technology in the Health Sciences
Educational Technology in the Health SciencesEducational Technology in the Health Sciences
Educational Technology in the Health Sciences
 
Accounting for Restricted Grants When and How To Record Properly
Accounting for Restricted Grants  When and How To Record ProperlyAccounting for Restricted Grants  When and How To Record Properly
Accounting for Restricted Grants When and How To Record Properly
 
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptxNEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
NEWSPAPERS - QUESTION 1 - REVISION POWERPOINT.pptx
 
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.pptLevel 3 NCEA - NZ: A  Nation In the Making 1872 - 1900 SML.ppt
Level 3 NCEA - NZ: A Nation In the Making 1872 - 1900 SML.ppt
 
Bossa N’ Roll Records by Ismael Vazquez.
Bossa N’ Roll Records by Ismael Vazquez.Bossa N’ Roll Records by Ismael Vazquez.
Bossa N’ Roll Records by Ismael Vazquez.
 
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
Elevate Your Nonprofit's Online Presence_ A Guide to Effective SEO Strategies...
 
Bonku-Babus-Friend by Sathyajith Ray (9)
Bonku-Babus-Friend by Sathyajith Ray  (9)Bonku-Babus-Friend by Sathyajith Ray  (9)
Bonku-Babus-Friend by Sathyajith Ray (9)
 
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdfمصحف القراءات العشر   أعد أحرف الخلاف سمير بسيوني.pdf
مصحف القراءات العشر أعد أحرف الخلاف سمير بسيوني.pdf
 
Oliver Asks for More by Charles Dickens (9)
Oliver Asks for More by Charles Dickens (9)Oliver Asks for More by Charles Dickens (9)
Oliver Asks for More by Charles Dickens (9)
 
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
BÀI TẬP BỔ TRỢ TIẾNG ANH LỚP 9 CẢ NĂM - GLOBAL SUCCESS - NĂM HỌC 2024-2025 - ...
 

INTERNSHIP REPORT (20).pptx

  • 1. INTERNSHIP REPORT AT PIRAMAL PHARAMACEUTICAL LIMITED INTERNSHIP BY -BARATH R (20-UCH-037)
  • 2. WAREHOUSE IN PHARMAECUTICAL INDUSTRY • To maintained Warehouse and Finished Goods area clean and presentable for audit.To follow Good Documentation practices and safety instructions & ensure compliance while working in warehouse. Receiving of Raw materials and Packing materials and Prepare Goods receipt Note (GRN). • Recording of Temperature, Relative Humidity and Differential Pressure in stores and Finished Goods area. Arrangements of Raw material and Packing material in stores according to the status i.e Under test Approved, Rejected and Quarantine etc. Dispensing and issue of Raw materials and Packing materials to production and Packing department as per respective Batch manufacturing and Packing record.
  • 3. • Handling of Damaged, Rejected and Expired materials in warehouse. To follow online documentation in Raw material, Packing material and Finished Goods store. Follow up with purchase and commercial department for disposal of non moving, obsolete and rejected raw and packing materials. Temperature mapping in Stores and Finished Goods area. Posting and Transaction of materials in SAP or ERP system. Follow up with Quality control department for timely sampling and release of materials. Preparation of Standard Operating Procedure related to warehouse department. To provide SOP Training to juniors or new joining persons. Responsible for Handling of Change control and Deviations. Prepare packing list and dispatch plan for Finished Goods and dispatch of Finished Goods. Identify the materials which are due for Retesting on monthly basis and inform to respective department for sampling of the same.
  • 4. PRODUCTION IN PHARMACEUTICAL INDUSTRY • Production should be performed and supervised by competent people.All handling of materials and products, such as receipt and quarantine, sampling, storage, labelling, dispensing, processing, packaging and distribution should be done in accordance with written procedures or instructions and, where necessary, recorded. • All incoming materials should be checked to ensure that the consignment corresponds to the order. Containers should be cleaned where necessary and labelled with the prescribed data. • Damage to containers and any other problem which might adversely affect the quality of a material should be investigated, recorded and reported to the Quality Control Department.
  • 5. • Incoming materials and finished products should be physically or administratively quarantined immediately after receipt or processing, until they have been released for use or distribution. • Intermediate and bulk products purchased as such should be handled on receipt as though they were starting materials. Checks on yields, and reconciliation of quantities, should be carried out as necessary to ensure that there are no discrepancies outside acceptable limits.Operations on different products should not be carried out simultaneously or consecutively in the same room unless there is no risk of mix-up or crosscontamination. • At every stage of processing, products and materials should be protected from microbial and other contamination.
  • 6. When working with dry materials and products, special precautions should be taken to prevent the generation and dissemination of dust. This applies particularly to the handling of highly active or sensitising materials. At all times during processing, all materials, bulk containers, major items of equipment and where appropriate rooms used should be labelled or otherwise identified with an indication of the product or material being processed, its strength (where applicable) and batch number. Where applicable, this indication should also mention the stage of production.
  • 7. R&D IN PHARMA INDUSTRY • The pharma R&D process is simply the series of activities targeted to reach the goal of discovering and delivering new medical drugs, devices, or therapies to market. • Very basically, R&D in the pharma industry involves: • Pre-clinical research and discovery of innovative drugs • Clinical testing of prescription drugs in trials • Preparation and submission of applications for Food and Drug Administration or FDA approval
  • 8. Designing production processes for the new product Clinical testing of a new drug against an existing drug to ultimately show the new product’s superior benefits Additional clinical trials after a new drug reaches the market, for safety monitoring and detection of additional side effects that may not have been observed in earlier trials during development Line extensions, or innovations and improvements for existing prescription drugs, which include developing new dosages and delivery systems and testing for additional potential uses
  • 9. Quality Control in the Pharmaceutical Industry
  • 10. • Analyzes are performed according to what each drug requires and depending on the phase this drug is in. In the physical-chemical laboratory, controls of all types are carried out, from the simplest to the most complex. We can mention as simple analyzes the product’s appearance, hardness, density and pH. As more complex, we can mention the most used method today in the largest pharmaceutical industries in the world, the content of the product (dosage), carried out in a device called HPLC (High Performance Liquid Chromatography). • Each product goes through a production process and in a physico-chemical laboratory it is analyzed from the raw material, passing through the initial product, final product and stability study. Each phase requires special attention in its tests, following the literature established by the countries of dispatch and consumption of the drug. In Portugal, the European Pharmacopoeia is used as the main literature.
  • 11. HIGH PERFOMANCE LIQUID CHROMATOGRAPHY IN PHARMACEUTICAL ANALYSES • The purpose high perfomance liquid chromatography (HPLC) analysis of any drugs is to confirm the identity of a drug and provide quantitative results and also to monitor the progress of the therapy of a disease • It may also be used to further our understanding of the normal and disease process in the human body trough biomedical and therapeutically research during investigation before of the drugs registration. The analyses of drugs and metabolites in biological fluids, particularly plasma, serum or urine is one of the most demanding but one of the most common uses of high performance of liquid chromatography. Blood, plasma or serum contains numerous endogenous compounds of ten present in concentrations much greater than those of analyte. Analiyte concentrations are often low, and in the case of drugs, the endogenous compounds are sometimes structurally very similar to the drug to be measured. The binding of drugs to the plasma protein also may occur which decreases the amount of free compound that is measured.
  • 12.
  • 13. • Liquid chromatography is an analytical technique that is used to separate a certain sample into its individual components.1 The separation occurs when the sample interacts with the mobile (liquid) and stationary phases (column). The various parts of the sample are separated out based on their polarities; they will have varying levels of affinity for the mobile phase, resulting in migration through the column at different speeds. • The mixed components are placed at the top of the column of the stationary phase, which is generally a fine adsorbent solid such as silica. This must be distributed evenly to minimise the presence of air bubbles that could influence the results of the test. The exit of the column is stoppered with glass, wool or a porous plate. When the mobile phase passes through, the mixture separates into bands. These can then be collected and analysed via other methods.1